GM Crop Database

Database Product Description

MON87751 (MON-87751-7)
Host Organism
Glycine max (Soybean)
Trait
Insect Resistance
Trait Introduction
Agrobacterium tumefaciens-mediated plant transformation.
Proposed Use

Production for human consumption and livestock feed.

Product Developer
Monsanto Company

Summary of Regulatory Approvals

Country Food Feed Environment Notes
Australia 2016
Canada 2014 2014 2014
Japan 2016 2016 2014
Korea 2016 2016
New Zealand 2016
Taiwan 2016
United States 2015 2015 2014

Introduction Expand

An insect-protected soybean line MON 87751 has been developed by Monsanto Company. This soybean was genetically engineered to produce the CrylA.105 and Cry2Ab2 insecticidal (Cry) proteins, which provide protection from feeding damage caused by targeted lepidopteran insect pests. 

Summary of Introduced Genetic Elements Expand

Code Name Type Promoter, other Terminator Copies Form
cry1A.105 chimeric cry1 delta-endotoxin IR

rbcS promoter and transit Peptide from Arabidopsis thaliana

Phosphate transporter gene terminator from Medicago truncatula

cry2Ab2 Cry2Ab2 delta-endotoxin IR

Actin 2 Gene promoter  and chloroplast transit peptide 2 from Arabidopsis thaliana

Metallothionein-like gene terminator from O. sativa (rice) 

Characteristics of Glycine max (Soybean) Expand

Center of Origin Reproduction Toxins Allergenicity

Southeast Asia; wild soybean species endemic in China, Korea, Japan, Taiwan.

Self-polinated; rarely displays any dormancy characteristics; does not compete well with other cultivated plants.

Raw soybeans contain trypsin inhibitors, which are toxin when eaten.

Soy allergies are common, and eating soy products can cause rashes and swelling of the skin in sensitive individuals.

Donor Organism Characteristics Expand

Latin Name Gene Pathogenicity
Bacillus thuringiensis var. aizawai cry1A.105

While target insects are susceptible to oral doses of Bt proteins, no evidence of toxic effects in laboratory mammals or birds.

Bacillus thuringiensis subsp. kurstaki cry2Ab2

While target insects are susceptible to oral doses of Bt proteins, no evidence of toxic effects in laboratory mammals or birds.

Modification Method Expand

Coming soon.

Characteristics of the Modification Expand

Coming soon.

Environmental Safety Considerations Expand

Coming soon.

Food and/or Feed Safety Considerations Expand

Coming soon.

Links to Further Information Expand


This record was last modified on Friday, February 17, 2017